Pacific Biosciences of California Inc
NASDAQ:PACB

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
NASDAQ:PACB
Watchlist
Price: 1.27 USD -5.93% Market Closed
Market Cap: $383.4m

Wall Street
Price Targets

PACB Price Targets Summary
Pacific Biosciences of California Inc

Wall Street analysts forecast PACB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PACB is 2.48 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.

Lowest
Price Target
1.01 USD
20% Downside
Average
Price Target
2.48 USD
95% Upside
Highest
Price Target
3.15 USD
148% Upside
Pacific Biosciences of California Inc Competitors:
Price Targets
GLSI
Greenwich Lifesciences Inc
83% Upside
SDA
Goldenbridge Acquisition Ltd
148% Upside

Revenue
Forecast

12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Pacific Biosciences of California Inc's revenue is 12%. The projected CAGR for the next 3 years is 13%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PACB's stock price target?
Price Target
2.48 USD

According to Wall Street analysts, the average 1-year price target for PACB is 2.48 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.

What is Pacific Biosciences of California Inc's Revenue forecast?
Projected CAGR
13%

For the last 14 years the compound annual growth rate for Pacific Biosciences of California Inc's revenue is 12%. The projected CAGR for the next 3 years is 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett